Advisor Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $1.65M | Buy |
26,634
+7,894
| +42% | +$489K | 0.12% | 188 |
|
|
2022
Q1 | $1.11M | Sell |
18,740
-7,606
| -29% | -$486K | 0.07% | 276 |
|
|
2021
Q4 | $1.91M | Buy |
26,346
+2,351
| +10% | +$162K | 0.12% | 174 |
|
|
2021
Q3 | $1.68M | Buy |
23,995
+3,098
| +15% | +$218K | 0.11% | 175 |
|
|
2021
Q2 | $1.44M | Buy |
20,897
+1,968
| +10% | +$131K | 0.09% | 209 |
|
|
2021
Q1 | $1.22M | Buy |
18,929
+2,205
| +13% | +$142K | 0.09% | 226 |
|
|
2020
Q4 | $974K | Sell |
16,724
-15,356
| -48% | -$927K | 0.07% | 260 |
|
|
2020
Q3 | $2.03M | Sell |
32,080
-20,545
| -39% | -$1.42M | 0.17% | 112 |
|
|
2020
Q2 | $4.05M | Buy |
52,625
+2,491
| +5% | +$191K | 0.38% | 55 |
|
|
2020
Q1 | $3.75M | Buy |
50,134
+18,566
| +59% | +$1.28M | 0.45% | 51 |
|
|
2019
Q4 | $2.02M | Sell |
31,568
-1,034
| -3% | -$67.3K | 0.21% | 104 |
|
|
2019
Q3 | $2.07M | Buy |
32,602
+4,593
| +16% | +$300K | 0.25% | 80 |
|
|
2019
Q2 | $1.89M | Buy |
28,009
+5,587
| +25% | +$368K | 0.23% | 84 |
|
|
2019
Q1 | $1.46M | Buy |
22,422
+697
| +3% | +$46.3K | 0.19% | 104 |
|
|
2018
Q4 | $1.36M | Sell |
21,725
-5,427
| -20% | -$379K | 0.22% | 102 |
|
|
2018
Q3 | $2.1M | Buy |
27,152
+1,699
| +7% | +$128K | 0.28% | 70 |
|
|
2018
Q2 | $1.8M | Sell |
25,453
-228
| -0.9% | -$16.1K | 0.3% | 69 |
|
|
2018
Q1 | $1.94M | Buy |
25,681
+1,332
| +5% | +$106K | 0.36% | 58 |
|
|
2017
Q4 | $1.97M | Buy |
24,349
+2,085
| +9% | +$158K | 0.35% | 58 |
|
|
2017
Q3 | $1.8M | Buy |
22,264
+631
| +3% | +$48.3K | 0.35% | 56 |
|
|
2017
Q2 | $1.53M | Buy |
21,633
+6,137
| +40% | +$408K | 0.36% | 63 |
|
|
2017
Q1 | $1.05M | Sell |
15,496
-3,404
| -18% | -$239K | 0.28% | 89 |
|
|
2016
Q4 | $1.35M | Buy |
18,900
+1,017
| +6% | +$75.6K | 0.41% | 59 |
|
|
2016
Q3 | $1.42M | Sell |
17,883
-678
| -4% | -$55.1K | 0.47% | 47 |
|
|
2016
Q2 | $1.55M | Sell |
18,561
-566
| -3% | -$50.2K | 0.54% | 43 |
|
|
2016
Q1 | $1.76M | Sell |
19,127
-8,182
| -30% | -$738K | 0.65% | 38 |
|
|
2015
Q4 | $2.76M | Buy |
27,309
+376
| +1% | +$39.1K | 0.94% | 22 |
|
|
2015
Q3 | $2.69M | Buy |
26,933
+961
| +4% | +$107K | 1.13% | 15 |
|
|
2015
Q2 | $2.71M | Buy |
25,972
+1,611
| +7% | +$176K | 1.04% | 15 |
|
|
2015
Q1 | $2.39M | Buy |
24,361
+1,057
| +5% | +$107K | 1.02% | 16 |
|
|
2014
Q4 | $2.32M | Sell |
23,304
-541
| -2% | -$56K | 1.02% | 16 |
|
|
2014
Q3 | $2.54M | Buy |
23,845
+684
| +3% | +$67K | 1.45% | 10 |
|
|
2014
Q2 | $1.92M | Buy |
23,161
+1,259
| +6% | +$98K | 0.95% | 20 |
|
|
2014
Q1 | $1.55M | Buy |
21,902
+708
| +3% | +$55.5K | 0.85% | 27 |
|
|
2013
Q4 | $1.59M | Buy |
21,194
+1,731
| +9% | +$121K | 0.92% | 24 |
|
|
2013
Q3 | $1.22M | Buy |
19,463
+1,174
| +6% | +$70.2K | 0.87% | 30 |
|
|
2013
Q2 | $938K | Buy |
+18,289
| New | +$953K | 0.77% | 36 |
|
Other funds holding GILD
Advisor Partners's GILD Position: Q2 2022 in Review
Advisor Partners increased its Gilead Sciences (GILD) stake by 42% in Q2 2022, buying an estimated $489K and bringing the position to 26,634 shares worth $1.65M. The position accounts for 0.12% of the portfolio, ranked #188.
Advisor Partners first reported a position in GILD in Q2 2013 and has held it in 37 quarters since. The position peaked at $4.05M in Q2 2020. 1,604 funds tracked by Wall St. Rank hold GILD as of Q2 2022.
- Advisor Partners held 26,634 shares of Gilead Sciences worth $1.65M as of Q2 2022.
- Advisor Partners bought 7,894 Gilead Sciences shares in Q2 2022, an estimated $489K.
- Gilead Sciences made up 0.12% of Advisor Partners's portfolio in Q2 2022, its #188 holding.
- Advisor Partners first reported a position in Gilead Sciences in Q2 2013 and has held it in 37 quarters since.
- Advisor Partners's Gilead Sciences position peaked at $4.05M in Q2 2020.
- 1,604 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2022.
Based on Advisor Partners's 13F filing for Q2 2022, filed 11 Aug 2022.